We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

35 hedge funds and large institutions have $7.12M invested in AIM ImmunoTech in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $6.86M → $7.12M (+$259K)

15% less funds holding

Funds holding: 41 → 35 (-6)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

77% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 13

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$40.2K
2
VF
Virtu Financial
New York
+$11.4K
3
State Street
State Street
Massachusetts
+$10.9K
4
SWM
SeaCrest Wealth Management
New York
+$1.29K
5
CFN
Cordasco Financial Network
Florida
+$431

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$239K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$188K
3
BCM
Bridgeway Capital Management
Texas
-$47.4K
4
RJFSA
Raymond James Financial Services Advisors
Florida
-$45K
5
Morgan Stanley
Morgan Stanley
New York
-$42.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
HR
26
Howe & Rusling
New York
$2K – – –
SC
27
Stephens Consulting
Michigan
$1.59K -$1.29K -15 -50%
Osaic Holdings
28
Osaic Holdings
Arizona
$1K -$1.72K -20 -57%
CFGS
29
Concourse Financial Group Securities
Alabama
$1K – – –
HI
30
Hoey Investments
Pennsylvania
$1K – – –
CFN
31
Cordasco Financial Network
Florida
$1K +$431 +5 New
APA
32
American Portfolios Advisors
New York
$242 – – –
TWC
33
TD Waterhouse Canada
Ontario, Canada
$226 – – –
RJFSA
34
Raymond James Financial Services Advisors
Florida
– -$45K -485 Closed
Citadel Advisors
35
Citadel Advisors
Florida
– -$37K -411 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
– -$35K -378 Closed
HighTower Advisors
37
HighTower Advisors
Illinois
– -$22K -241 Closed
WG
38
Winton Group
United Kingdom
– -$14K -157 Closed
Jane Street
39
Jane Street
New York
– -$14K -155 Closed
TRCT
40
Tower Research Capital (TRC)
New York
– -$4.05K -47 -96%
JP Morgan Chase
41
JP Morgan Chase
New York
– -$2.24K -26 Closed
1
2

AIM Hedge Fund Activity: Q1 2022 in Review

35 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2022, worth a combined $7.12M — up 3.8% from $6.86M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AIM and 2 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 3 added.

The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $40.2K. The largest seller was Renaissance Technologies, cutting an estimated $239K.

  • 35 institutional investors held AIM ImmunoTech (AIM) as of Q1 2022, down from 41 in Q4 2021.
  • Funds reported $7.12M of AIM ImmunoTech stock for Q1 2022, up 3.8% quarter-over-quarter.
  • 2 funds opened new AIM ImmunoTech positions in Q1 2022 and 8 closed out, a net change of -6 holders.
  • The largest AIM ImmunoTech buyer in Q1 2022 was Cambridge Investment Research Advisors, an estimated $40.2K added.
  • The largest AIM ImmunoTech seller in Q1 2022 was Renaissance Technologies, an estimated $239K sold.

Based on aggregated 13F filings for Q1 2022.